PMID- 17669398 OWN - NLM STAT- MEDLINE DCOM- 20071105 LR - 20211203 IS - 0014-4827 (Print) IS - 0014-4827 (Linking) VI - 313 IP - 16 DP - 2007 Oct 1 TI - Activation of adenosine monophosphate activated protein kinase inhibits growth of multiple myeloma cells. PG - 3592-603 AB - The role of adenosine monophosphate activated protein kinase (AMPK) in regulating multiple myeloma (MM) cell growth is not yet clear. In this study, we show that the AMPK activators 5-aminoimidazole-4-carboxamide riboside (AICAr) and D942 inhibit cell growth in MM cell lines. AICAr also induced an S-phase cell cycle arrest in all four tested cell lines and led to phosphorylation and thus activation of AMPK. Furthermore, the inhibition of a nucleoside transporter by nitrobenzyl-thio-9-beta-d-ribofuranosylpurine (NBTI), inhibition of the adenosine kinase by iodotubericidine and inhibition of AMPK by AMPKI Compound C reversed AICAr effects, indicating that the cellular effects of AICAr were mediated by AMPK. Activation of AMPK inhibited basal extracellular signal-regulated kinase (ERK), mammalian target of rapamycin (mTOR) and P70S6 kinase (P70S6K) as well as AKT phosphorylation, and blocked IL-6, IGF-1, and HS-5 stromal cell conditioned medium-induced increase of cell growth. Troglitazone, which has previously been shown to activate AMPK, similarly inhibited MM cell growth, activated AMPK, and decreased ERK and P70S6K phosphorylation. Our results suggest that activation of AMPK inhibits MM cell growth despite stimulation with IL-6, IGF-1, or HS-5 stromal cell conditioned medium and represents a potential new target in the therapy of MM. FAU - Baumann, Philipp AU - Baumann P AD - Department of Hematology and Oncology, Medizinische Klinik Innenstadt, Klinikum der Universitat Munchen, Germany. philipp.baumann@med.uni-muenchen.de FAU - Mandl-Weber, Sonja AU - Mandl-Weber S FAU - Emmerich, Bertold AU - Emmerich B FAU - Straka, Christian AU - Straka C FAU - Schmidmaier, Ralf AU - Schmidmaier R LA - eng PT - Journal Article DEP - 20070704 PL - United States TA - Exp Cell Res JT - Experimental cell research JID - 0373226 RN - 0 (Chromans) RN - 0 (Culture Media, Conditioned) RN - 0 (Interleukin-6) RN - 0 (Multienzyme Complexes) RN - 0 (Ribonucleotides) RN - 0 (Thiazolidinediones) RN - 360-97-4 (Aminoimidazole Carboxamide) RN - 67763-96-6 (Insulin-Like Growth Factor I) RN - EC 2.7.- (Protein Kinases) RN - EC 2.7.1.1 (MTOR protein, human) RN - EC 2.7.11.1 (Protein Serine-Threonine Kinases) RN - EC 2.7.11.1 (Ribosomal Protein S6 Kinases, 70-kDa) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) RN - EC 2.7.11.24 (Extracellular Signal-Regulated MAP Kinases) RN - EC 2.7.11.31 (AMP-Activated Protein Kinases) RN - F0X88YW0YK (AICA ribonucleotide) RN - I66ZZ0ZN0E (Troglitazone) SB - IM MH - AMP-Activated Protein Kinases MH - Aminoimidazole Carboxamide/analogs & derivatives/pharmacology MH - Cell Line, Tumor MH - Cell Proliferation/drug effects MH - Chromans/pharmacology MH - Culture Media, Conditioned MH - Enzyme Activation/drug effects MH - Extracellular Signal-Regulated MAP Kinases/metabolism MH - Humans MH - Insulin-Like Growth Factor I/pharmacology MH - Interleukin-6/pharmacology MH - Multienzyme Complexes/*metabolism MH - Multiple Myeloma/*enzymology/*pathology MH - Phosphorylation/drug effects MH - Protein Kinases/metabolism MH - Protein Serine-Threonine Kinases/*metabolism MH - Ribonucleotides/pharmacology MH - Ribosomal Protein S6 Kinases, 70-kDa/metabolism MH - S Phase/drug effects MH - Signal Transduction/drug effects MH - Stromal Cells/drug effects MH - TOR Serine-Threonine Kinases MH - Thiazolidinediones/pharmacology MH - Troglitazone EDAT- 2007/08/03 09:00 MHDA- 2007/11/06 09:00 CRDT- 2007/08/03 09:00 PHST- 2007/03/08 00:00 [received] PHST- 2007/06/14 00:00 [revised] PHST- 2007/06/15 00:00 [accepted] PHST- 2007/08/03 09:00 [pubmed] PHST- 2007/11/06 09:00 [medline] PHST- 2007/08/03 09:00 [entrez] AID - S0014-4827(07)00279-0 [pii] AID - 10.1016/j.yexcr.2007.06.020 [doi] PST - ppublish SO - Exp Cell Res. 2007 Oct 1;313(16):3592-603. doi: 10.1016/j.yexcr.2007.06.020. Epub 2007 Jul 4.